Institut Du Cancer De Montpellier - Val D'aurelle

This study looks at giving a single dose of radiation directly to the tumor site during breast-conserving surgery for women aged 60 and older with early-stage, hormone-sensitive breast cancer. The goal is to see if this shorter, more targeted approach works as well as standard we…

This study tests whether adding a special chemotherapy spray (PIPAC) directly into the abdomen to standard IV chemo can help people with peritoneal mesothelioma live longer. About 66 adults who have not had prior treatment will be randomly assigned to get either standard chemo al…

This study tests whether a new tracking system (Calypso) that follows the prostate's movement during radiation can reduce long-term side effects compared to standard image-guided radiation. About 74 men with low- or intermediate-risk prostate cancer will take part. The goal is to…

This study looks at whether giving an extra dose of radiation (16Gy) to the tumor area after standard whole-breast radiation (50Gy) helps prevent breast cancer from coming back in women with a very early form called ductal carcinoma in situ (DCIS). About 2004 women who had breast…

This study tests whether combining two drugs (regorafenib and irinotecan) works better than regorafenib alone for people with metastatic colorectal cancer who have run out of standard treatment options. About 377 adults with a specific genetic marker (A/A genotype of cyclin D1) w…

This study aims to validate a new test that measures tiny molecules called microRNAs in thyroid nodule samples. The goal is to more accurately tell if a nodule is cancerous or not, especially when standard tests are unclear. Researchers will compare the test results with ultrasou…

This study tests whether adding a special yoga and physiotherapy program to standard care can lower stress in women undergoing brachytherapy for cervical cancer. About 98 women will take part, and their stress levels will be measured 15 days after treatment starts. The program is…